ADD CONDITION

items per page

Post Peel Protectant

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Hydrocortisone 7.5 g/100 mL
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2015
Label revision date
January 15, 2020
Active ingredient
Hydrocortisone 7.5 g/100 mL
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2015
Label revision date
January 15, 2020
Manufacturer
Vi Medical Products Inc.
Registration number
part348
NDC root
70484-006

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Hydrocortisone is a type of medication commonly used as an anti-itch cream and post-peel protectant. It is part of the Vitality Institute Skin Care System and comes in a 30 mL (1 FL OZ) container. This cream helps relieve itching and discomfort associated with various skin conditions, providing soothing relief to your skin.

If you are considering using hydrocortisone, it's important to consult with a doctor to ensure it is appropriate for your situation, especially if your symptoms persist or worsen.

Uses

You can use this product as a post-peel protectant, which helps to soothe and protect your skin after cosmetic procedures like chemical peels. It’s also effective as an anti-itch cream, providing relief from itching caused by various skin irritations.

Rest assured, this product does not have any teratogenic effects, meaning it does not cause harm to a developing fetus.

Dosage and Administration

When using this medication, you should apply it to the affected area no more than 3 to 4 times a day. This guideline applies to both adults and children aged 2 years and older. If your child is under 2 years old, it’s important not to use this medication without first consulting a doctor. Always follow these instructions to ensure safe and effective use.

What to Avoid

It's important to keep this medication out of reach of children. If a child accidentally swallows it, seek medical help or contact a Poison Control Center immediately. There are no specific contraindications, risks of abuse or misuse, or concerns about dependence associated with this medication, but always use it responsibly and as directed.

Side Effects

When using this medication, it's important to remember that it is for external use only, so you should not ingest it. Additionally, be careful to avoid contact with your eyes, as this could lead to irritation or other issues. Always follow these guidelines to ensure your safety while using the product.

Warnings and Precautions

This product is for external use only, so please avoid applying it to your eyes or ingesting it. If you accidentally swallow any of it, seek emergency medical help or contact a Poison Control Center immediately.

While there are no specific instructions for stopping use or general precautions, it's always a good idea to consult your doctor if you have any concerns or experience unusual reactions. Your health and safety are important, so don’t hesitate to reach out for guidance.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to be safe and get checked by a healthcare professional if you have any concerns about your health. Remember, timely intervention can make a significant difference.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to be cautious with hydrocortisone cream, as its safety during pregnancy has not been established. You should consult your doctor before using this medication, as the potential risks to your fetus are not clearly defined.

There are no specific dosage modifications recommended for pregnant individuals, so it's best to seek guidance from a healthcare professional regarding its use. Always prioritize your health and the health of your baby by discussing any medications with your doctor.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or recommendations regarding the use of this product while nursing. Additionally, there are no particular considerations or precautions mentioned for lactation. This means that, based on the available information, you can use this product without concern for its effects on your milk production or your nursing infant. Always consult with your healthcare provider if you have any questions or concerns about your specific situation.

Pediatric Use

If your child is under 2 years old, it's important not to use this medication without first consulting a doctor. For children aged 2 and older, you can apply the medication to the affected area, but be sure to do this no more than 3 to 4 times a day. Always follow these guidelines to ensure your child's safety and well-being.

Geriatric Use

While there is no specific information available about the use of this medication in older adults, it’s important to approach any new treatment with caution. As you age, your body may process medications differently, and factors like kidney function (renal impairment) and changes in cognition can affect how well a drug works or how it may impact you.

If you are an older adult or a caregiver, it’s wise to discuss any concerns with your healthcare provider. They can help determine the best approach for your individual health needs, ensuring that any medication you take is safe and effective for you. Always keep your doctor informed about all medications you are taking, as this can help prevent potential interactions or side effects.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment plan is safe and effective for your specific situation. They can help monitor your kidney health and make any necessary adjustments to your medications.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication should be used if you have hepatic impairment (liver issues).

Always consult your healthcare provider for personalized advice and to ensure that any medication you take is safe for your liver health. They can help determine the best approach for your treatment based on your individual circumstances.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. In this case, there are no known drug interactions or laboratory test interactions associated with the medication. However, always ensure that your healthcare provider is aware of all the medications you are using, as this helps them provide the best care tailored to your needs.

By discussing your full medical history and any other treatments, you can help prevent potential issues and ensure your safety.

Storage and Handling

To ensure the best performance of your product, store it at a temperature between 20°C to 25°C (68°F to 77°F). It’s acceptable for the temperature to occasionally range from 15°C to 30°C (59°F to 86°F). Make sure to keep the product protected from light, as exposure can affect its quality. When not in use, always keep the tube tightly closed to maintain its integrity. Remember to discard the product after opening to ensure safety and effectiveness.

Additional Information

You should apply this medication topically to the affected area, using it no more than 3 to 4 times a day if you are an adult or a child over 2 years old. If the patient is under 2 years of age, it is important to consult a doctor before use. There are no additional details available regarding laboratory tests, abuse potential, or postmarketing experiences related to this medication.

FAQ

What is Hydrocortisone used for?

Hydrocortisone is used as a post peel protectant and an anti-itch cream.

How should I apply Hydrocortisone?

For adults and children over 2 years, apply to the affected area no more than 3 to 4 times daily. Do not use in children under 2 years without consulting a doctor.

What should I do if my condition worsens or does not improve?

Stop use and ask a doctor if your condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days.

Is Hydrocortisone safe to use during pregnancy?

The safety of Hydrocortisone during pregnancy has not been established. Consult a doctor if you are pregnant or planning to become pregnant.

What precautions should I take when using Hydrocortisone?

Use Hydrocortisone for external use only and avoid contact with eyes. Keep it out of reach of children.

What should I do if I accidentally swallow Hydrocortisone?

If swallowed, get medical help or contact a Poison Control Center right away.

How should I store Hydrocortisone?

Store Hydrocortisone at 20°C to 25°C (68°F to 77°F), protect it from light, and keep the tube tightly closed when not in use.

Packaging Info

Below are the non-prescription pack sizes of Post Peel Protectant (hydrocortisone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Post Peel Protectant.
Details

Drug Information (PDF)

This file contains official product information for Post Peel Protectant, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

Vitality Institute Skin Care System includes a Post Peel Protectant formulated as an anti-itch cream. This product is available in a 30 mL (1 FL OZ) dosage form, designed to provide relief and protection following skin peel procedures.

Uses and Indications

This drug is indicated for use as a post-peel protectant and as an anti-itch cream. It is designed to provide relief and protection following dermatological procedures, such as chemical peels, and to alleviate itching associated with various skin conditions.

There are no teratogenic effects associated with this drug, and no nonteratogenic effects have been reported.

Dosage and Administration

For adults and children aged 2 years and older, the recommended application is to the affected area not more than 3 to 4 times daily. It is important to ensure that the application is performed with clean hands and that the affected area is properly prepared prior to administration.

For children under 2 years of age, the product should not be used without consulting a healthcare professional.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes to prevent irritation or injury.

In the event of accidental ingestion, immediate medical assistance should be sought. Healthcare professionals are advised to contact a Poison Control Center or seek emergency medical help without delay.

Patients should be instructed to discontinue use and consult their healthcare provider if any adverse reactions occur, although specific instructions for cessation were not provided in the available information.

No specific general precautions or laboratory tests have been outlined; however, healthcare professionals should remain vigilant and monitor patients for any unexpected side effects or complications associated with the use of this product.

Side Effects

Patients should be advised that the product is for external use only and must be kept away from the eyes to prevent irritation or injury. Adverse reactions related to improper use may occur, and it is essential for patients to follow the instructions provided to minimize risks.

In clinical practice, participants have reported various reactions when the product is not used as directed. It is crucial for healthcare providers to educate patients on the importance of adhering to these guidelines to ensure safe and effective use.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Post Peel Protectant (hydrocortisone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Post Peel Protectant.
Details

Pediatric Use

Pediatric patients under 2 years of age should not use this medication without consulting a doctor. For children aged 2 years and older, the medication may be applied to the affected area no more than 3 to 4 times daily. Care should be taken to adhere to these guidelines to ensure safety and efficacy in pediatric use.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The safety of hydrocortisone cream during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare professional before use. While potential risks to the fetus are not clearly defined, caution is advised when considering the use of this medication during pregnancy. There are no specific dosage modifications for pregnant individuals; therefore, it is essential to seek guidance from a healthcare professional regarding appropriate use in this population.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there are no specific considerations or precautions mentioned concerning lactation. Therefore, healthcare professionals may consider the use of this product in nursing mothers without specific concerns related to breastfeeding.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and ensuring adequate circulation. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and is deemed appropriate based on clinical judgment.

Furthermore, it is crucial to consult local poison control centers or toxicology experts for guidance on specific management protocols and antidotes, if applicable. Continuous monitoring and supportive measures should be maintained until the patient is stabilized and further evaluation can be conducted.

Documentation of the incident, including the substance involved, estimated dose, time of exposure, and any interventions performed, is vital for ongoing patient management and future reference.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the provided data.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help or contact a Poison Control Center immediately. It is essential for patients to understand the importance of these precautions to ensure their safety and the safety of others.

Storage and Handling

The product is supplied in a tube format, with specific storage and handling requirements to ensure its integrity and efficacy. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F), with permissible excursions between 15°C to 30°C (59°F to 86°F).

To maintain product quality, it is essential to protect the tube from light exposure. Additionally, the tube must be kept tightly closed when not in use to prevent contamination and degradation. It is important to note that the product should be discarded after opening to ensure safety and effectiveness.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of 3 to 4 times daily for adults and children aged 2 years and older. For children under 2 years of age, it is advised not to use the medication without consulting a doctor. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Post Peel Protectant, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Post Peel Protectant, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.